Skip to main content
placeholder image

Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor

Journal Article


Abstract


Publication Date


  • 2015

Citation


  • Devineni, D., Curtin, C. R., Marbury, T. C., Smith, W., Vaccaro, N., Wexler, D., . . . Wajs, E. (2015). Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor. CLINICAL THERAPEUTICS, 37(3), 610-628. doi:10.1016/j.clinthera.2014.12.013

Number Of Pages


  • 19

Start Page


  • 610

End Page


  • 628

Volume


  • 37

Issue


  • 3

Abstract


Publication Date


  • 2015

Citation


  • Devineni, D., Curtin, C. R., Marbury, T. C., Smith, W., Vaccaro, N., Wexler, D., . . . Wajs, E. (2015). Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor. CLINICAL THERAPEUTICS, 37(3), 610-628. doi:10.1016/j.clinthera.2014.12.013

Number Of Pages


  • 19

Start Page


  • 610

End Page


  • 628

Volume


  • 37

Issue


  • 3